Holmusk partners with Merck to focus on diabetes & prediabetes patients in APAC
Singapore, Nov. 11 -- based Holmusk has announced a collaboration with the healthcare business sector of Merck, to support patients and physicians in Asia-Pacific (APAC) with a holistic treatment approach for prediabetes and diabetes.
This partnership involves Holmusk's GlycoLeap, a leading mobile digital therapeutics platform that utilizes a highly data-driven approach to deliver personalized dietary feedback, interactive educational lessons, and 1-1 guidance with a qualified health coach. The goal is to help patients achieve weight loss and improved blood glucose control.
Lifestyle and behavior change are foundational for good management of patients with prediabetes & diabetes, yet often difficult to implement by healthcare providers ...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.